BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 25526222)

  • 1. Application of two direct C(sp3)-H functionalizations for total synthesis of (+)-lactacystin.
    Yoshioka S; Nagatomo M; Inoue M
    Org Lett; 2015 Jan; 17(1):90-3. PubMed ID: 25526222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of Synthetic Strategies for Densely Oxygenated Natural Products: Total Synthesis of Lactacystin and Zaragozic Acid C Using Photochemical C(sp
    Nagatomo M
    Yakugaku Zasshi; 2019; 139(5):651-661. PubMed ID: 31061332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total synthesis of lactacystin and salinosporamide A.
    Shibasaki M; Kanai M; Fukuda N
    Chem Asian J; 2007 Jan; 2(1):20-38. PubMed ID: 17441136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Total Synthesis of Salinosporamide A.
    Marx LB; Burton JW
    Chemistry; 2018 May; 24(26):6747-6754. PubMed ID: 29415322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A concise route to (+)-lactacystin.
    Ooi H; Ishibashi N; Iwabuchi Y; Ishihara J; Hatakeyama S
    J Org Chem; 2004 Oct; 69(22):7765-8. PubMed ID: 15498013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A formal synthesis of (+)-lactacystin.
    Wardrop DJ; Bowen EG
    Chem Commun (Camb); 2005 Oct; (40):5106-8. PubMed ID: 16220186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha,beta-unsaturated beta-silyl imide substrates for catalytic, enantioselective conjugate additions: a total synthesis of (+)-lactacystin and the discovery of a new proteasome inhibitor.
    Balskus EP; Jacobsen EN
    J Am Chem Soc; 2006 May; 128(21):6810-2. PubMed ID: 16719460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cystargolides, 20S Proteasome Inhibitors Isolated from Kitasatospora cystarginea.
    Gill KA; Berrué F; Arens JC; Carr G; Kerr RG
    J Nat Prod; 2015 Apr; 78(4):822-6. PubMed ID: 25769015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient total synthesis of novel bioactive microbial metabolites.
    Sunazuka T; Hirose T; Omura S
    Acc Chem Res; 2008 Feb; 41(2):302-14. PubMed ID: 18217720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereospecific total syntheses of proteasome inhibitors omuralide and lactacystin.
    Gu W; Silverman RB
    J Org Chem; 2011 Oct; 76(20):8287-93. PubMed ID: 21916437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short and versatile route to a key intermediate for lactacystin synthesis.
    Bulman Page PC; Hamzah AS; Leach DC; Allin SM; Andrews DM; Rassias GA
    Org Lett; 2003 Feb; 5(3):353-5. PubMed ID: 12556190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catalytic asymmetric total synthesis of (+)-lactacystin.
    Fukuda N; Sasaki K; Sastry TV; Kanai M; Shibasaki M
    J Org Chem; 2006 Feb; 71(3):1220-5. PubMed ID: 16438540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoproteasome inhibition and bioactivity of thiasyrbactins.
    Bakas NA; Schultz CR; Yco LP; Roberts CC; Chang CA; Bachmann AS; Pirrung MC
    Bioorg Med Chem; 2018 Jan; 26(2):401-412. PubMed ID: 29269255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cinnabaramides A-G: analogues of lactacystin and salinosporamide from a terrestrial streptomycete.
    Stadler M; Bitzer J; Mayer-Bartschmid A; Müller H; Benet-Buchholz J; Gantner F; Tichy HV; Reinemer P; Bacon KB
    J Nat Prod; 2007 Feb; 70(2):246-52. PubMed ID: 17249727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteasome inhibitor lactacystin ablates liver injury induced by intestinal ischaemia-reperfusion.
    Yao JH; Li YH; Wang ZZ; Zhang XS; Wang YZ; Yuan JC; Zhou Q; Liu KX; Tian XF
    Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1102-8. PubMed ID: 17880361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A concise and straightforward total synthesis of (+/-)-salinosporamide A, based on a biosynthesis model.
    Mulholland NP; Pattenden G; Walters IA
    Org Biomol Chem; 2008 Aug; 6(15):2782-9. PubMed ID: 18633536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Design, synthesis and biological assay of novel tripeptidic tetrazoles as inhibitors of 20S proteasome].
    Ma YH; Xu B; Cui JR; Yang ZJ; Zhang LR; Zhang LH
    Yao Xue Xue Bao; 2012 Apr; 47(4):472-8. PubMed ID: 22799029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dimerized linear mimics of a natural cyclopeptide (TMC-95A) are potent noncovalent inhibitors of the eukaryotic 20S proteasome.
    Desvergne A; Genin E; Maréchal X; Gallastegui N; Dufau L; Richy N; Groll M; Vidal J; Reboud-Ravaux M
    J Med Chem; 2013 Apr; 56(8):3367-78. PubMed ID: 23540790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of the ammonia-free Birch reduction of electron-deficient pyrroles: total synthesis of the 20s proteasome inhibitor, clasto-lactacystin beta-lactone.
    Donohoe TJ; Sintim HO; Sisangia L; Ace KW; Guyo PM; Cowley A; Harling JD
    Chemistry; 2005 Jul; 11(14):4227-38. PubMed ID: 15864801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concise Chemoenzymatic Total Synthesis and Identification of Cellular Targets of Cepafungin I.
    Amatuni A; Shuster A; Adibekian A; Renata H
    Cell Chem Biol; 2020 Oct; 27(10):1318-1326.e18. PubMed ID: 32763140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.